UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 65 filers reported holding UROGEN PHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $51,530,000 | -20.7% | 1,433,774 | -18.5% | 3.65% | -11.1% |
| Q1 2019 | $64,989,000 | -0.4% | 1,759,324 | +16.1% | 4.10% | -14.5% |
| Q4 2018 | $65,254,000 | -8.8% | 1,515,422 | 0.0% | 4.80% | +24.5% |
| Q3 2018 | $71,573,000 | -3.3% | 1,515,422 | +1.9% | 3.85% | -19.3% |
| Q2 2018 | $74,018,000 | +30.0% | 1,487,491 | +29.8% | 4.77% | -8.3% |
| Q1 2018 | $56,955,000 | +67.0% | 1,146,197 | +25.1% | 5.20% | +69.0% |
| Q4 2017 | $34,101,000 | – | 916,450 | – | 3.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |